Admelog Injection, Solution
NDC Package 70518-4275-0

11-digit billing NDC: 70518427500

Package Information

Admelog (insulin lispro) injection is aDMELOG is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. This formulation utilizes a injection, solution delivery system. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-4275 and is authorized under FDA application BLA209196.

Identification & Billing

NDC Package Code
70518-4275-0
Package Description
5 SYRINGE in 1 CARTON / 3 mL in 1 SYRINGE
Product Code
11-Digit Billing Format
70518427500
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Admelog
Non-Proprietary Name
Insulin Lispro
Substance Name
Insulin Lispro
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
Usage Information
ADMELOG is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.

Regulatory & Marketing

Labeler Name
Remedyrepack Inc.
Product Type
Human Prescription Drug
FDA Application #
BLA209196
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
02-04-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70518-4275-0 identifies a specific commercial package of 5 syringe in 1 carton / 3 ml in 1 syringe of Admelog, a human prescription drug labeled by Remedyrepack Inc.. This injection, solution is formulated for subcutaneous use and contains insulin lispro as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Remedyrepack Inc. on February 04, 2025. The current certification is valid through December 31, 2027.

How is this Remedyrepack Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518427500. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70518-4275-0
11-Digit CMS (5-4-2)
70518-4275-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.